Polycystic ovary syndrome (PCOS) is the
most common endocrine disorder in women
of reproductive age and affects between 10%
and 21% of women depending on the diag-
nostic criteria used and population assessed.
The condition has many short-term and
long-term complications, including repro-
ductive (such as, amenorrhoea, anovulation,
Inositol in Polycystic Ovarian Syndrome
Myo-inositol and d-chiro inositol show promise as a safe PCOS treatment
By Megan Chmelik, and Jacob Schor, ND, FABNO
Polycystic ovarian syndrome (PCOS) affects approximately 4% to 12% of reproductive age women. It is a leading cause of infertility and is also associated...
Forty-two overweight women with polycystic ovarian syndrome took myo-inositol and folic acid daily for 8 weeks. After the 8-week myo-inositol treatment, there was a significant reduction in LH/FSH ratio, FSH, prolactin, androstenedione, testosterone, insulin, and BMI compared to baseline; there was also a significant increase...